References
- Abo T, Roder J C, Abo W, Cooper M D, Balch C M. Natural killer (HNK-1 +) cells in Chédiak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest. 1982; 70: 193–197
- Brahmi Z. Nature of natural killer cell hyporresponsiveness in the Chédiak-Higashi syndrome. Hum Immunol. 1983; 6: 45–52
- Haliotis T, Roder J, Klein M, Ortaldo J, Fauci A S, Herberman R B. Chédiak-Higashi gene in humans: I. Impairment of natural-killer function. J Exp Med. 1980; 151: 1039–1048
- Klein M, Roder J, Haliotis T, Korec S. Chédiak-Higashi gene in humans: II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function. J Exp Med. 1980; 151: 1049–1058
- Niederwieser D, Gastl G, Rumpold H, Marth C, Kraft D, Huber C. Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after bone marrow transplantation (BMT). Br J Haematol. 1987; 65: 301–305
- Souza M HO, Diamond H R, Silva M LM. Immunological recovery after bone marrow transplantation for severe aplastic anaemia: a Brazilian experience. Eur J Hematol 1994; 53: 150–155
- Virelizier J L, Lagrue A, Durandy A, Arenzana F, Oury C, Griscelli C R. Reversal of natural killer defect in a patient with Chédiak-Higashi syndrome after bone-marrow transplantation. N Engl J Med. 1982; 306: 1055–1056
- Roder J C, Todd R F, Rubin P. The Chédiak-Higashi gene in humans: III. Studies on the mechanisms of NK impairment. Clin Exp Immunol. 1983; 51: 359–368
- Targan S R, Oseas R. The “lazy” NK cells of Chédiak-Higashi syndrome. J Immunol. 1983; 130: 2671–2674
- Katz P, Roder J C, Zaytoun A M, Herberman R B, Fauci A S. Mechanisms of human cell-mediated cytotoxicity: II. Correction of the selective defect in natural killing in the Chédiak-Hiagashi syndrome with inducers of intracellular cyclic GMP. J Immunol. 1982; 129: 297–302